Merck KGaA Ties Up Chord To Advance Cladribine Rare Disease Programs

Acquires Swiss Biotech To Expand Neurology Pipeline

 
• By Kevin Grogan
  
merck kgaa
The Darmstadt-based group is looking for bolt-ons • Source: merck kgaa
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Deals

More from Business